Novel technology for the diagnosis and monitoring
of iron toxicity, iron overload, in body fluids

News and Events

Recently published:

  1. Labile Plasma Iron (LPI) Is a Clinical Indicator of Overt Iron Overload in Patients with Lower-Risk Myelodysplastic Syndromes (MDS) Read more…
  2. The Extent of Labile Plasma Iron (LPI) Predicts for Non-Relapse-Mortality (NRM) in AML and MDS Patients with Systemic Iron Overload Undergoing Allogenic Stem Cell Transplantation Results of the Prospective Read more…

The Technology

Thalassemia, Hereditary Hemochromatosis and other health conditions associated with deranged metabolism or handling of iron often result in the development of acute and/or chronic Iron Overload...
 

Read more

Monitoring potential iron toxicity in iv iron supplementation used for the treatment of anemia in CKD patients
download PDF Read more…

FeROS™ eLPI – for the measurement of Non-Transferrin Bound Iron (NTBI)

FeROS™ LPI – for the measurement of Labile Plasma Iron (LPI)

Products are CE Marked for IVD use.

 

© Aferrix Ltd. - 3 Habosem St. Building 2, 2nd floor Ashdod 7761003 Israel
Tel: 972-52-5989926 - Fax: 077-4702271